Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€1.85
23.01.21
€60.00
23.01.22
-41.51%
24.01.22

Could be very worthwhile Investment >20% year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.16
23.01.21
€30.00
23.01.22
-67.09%
24.01.22

Could be very worthwhile Investment >20% year
buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€13.36
23.01.21
€100.00
23.01.22
-77.10%
24.01.22

Could be very worthwhile Investment >20% year
buy
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.62
23.01.21
€60.00
23.01.22
-81.94%
24.01.22

Could be very worthwhile Investment >20% year
buy
Arca Biopharma

Start price
Target price
Perf. (%)
€3.98
23.01.21
€30.00
23.01.22
-60.05%
24.01.22

Could be very worthwhile Investment >20% year
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.19
23.01.21
€20.00
23.01.22
-51.51%
24.01.22

Could be very worthwhile Investment >20% year
buy
Teligent Inc.

Start price
Target price
Perf. (%)
€0.99
23.01.21
-
23.01.22
-97.97%
24.01.22

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€35.75
23.01.21
-
23.01.22
-73.67%
24.01.22

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€17.60
10.01.22
-
10.01.23
-27.39%
23.01.22

Risky Investment
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.14
09.01.22
-
09.01.23
-5.80%
23.01.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.00
17.01.22
-
17.01.23
-44.67%
22.01.22

Risky Investment
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€3.67
21.01.21
€10.00
21.01.22
-28.61%
22.01.22

Could be very worthwhile Investment >20% year
buy
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€2.50
21.01.21
€10.00
21.01.22
-47.52%
22.01.22

Could be very worthwhile Investment >20% year
buy
Lipocine Inc.

Start price
Target price
Perf. (%)
€32.30
21.01.21
€136.00
21.01.22
-57.58%
22.01.22

Could be very worthwhile Investment >20% year
buy
Biocept Inc.

Start price
Target price
Perf. (%)
€147.00
21.01.21
€3,000.0
21.01.22
-48.16%
22.01.22

Could be very worthwhile Investment >20% year
buy
NanoVibronix Inc.

Start price
Target price
Perf. (%)
€30.00
04.10.21
-
04.10.22
-39.47%
10.01.22

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€18.94
05.01.22
-
05.01.23
-7.08%
09.01.22

Risky Investment
NanoVibronix Inc.

Start price
Target price
Perf. (%)
€52.08
13.08.21
€20.00
13.08.22
-65.13%
08.01.22

Probably not worthwhile Investment
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 10% per year
BiondVax Pharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€22.60
28.12.21
-
28.12.22
-32.74%
07.01.22

Probably not worthwhile Investment
Tenax Therapeutics Inc.

Start price
Target price
Perf. (%)
€30.38
30.12.20
-
30.12.21
-41.67%
31.12.21

Probably not worthwhile Investment
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€23.29
13.12.21
€20.00
13.12.22
-12.88%
30.12.21

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
BiondVax Pharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€24.60
22.12.21
-
22.12.22
-15.45%
25.12.21

Risky Investment
buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€1.03
17.02.21
€3.00
17.02.22
-24.32%
25.12.21

Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€22.15
12.04.21
€28.35
12.04.22
-51.96%
24.12.21

Could be worthwhile Investment >10% per year
CEL-SCI Corp.

Start price
Target price
Perf. (%)
€9.80
22.10.21
€1.00
22.10.22
-27.76%
16.12.21

Could be very worthwhile Investment >20% year